Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam

Poly(lactide-co-glycolide) (PLGA) polymers have been widely used for drug delivery due to their biodegradability and biocompatibility. One of the objectives of encapsulating a drug in PLGA microparticles (MPs) is to achieve an extended supply of the drug through sustained release, which can range fr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of controlled release 2023-01, Vol.353, p.823-831
Hauptverfasser:	Pei, Yihua, Wang, Jianping, Khaliq, Nisar Ul, Meng, Fanfei, Oucherif, Kaoutar A., Xue, Jie, Horava, Sarena D., Cox, Amy L., Richard, Coralie A., Swinney, Monica R., Park, Kinam, Yeo, Yoon
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Drug Delivery Systems Drug Liberation In vitro-in vivo correlation Meloxicam Microspheres Particle Size PLGA microparticles Polyglactin 910 Polylactic Acid-Polyglycolic Acid Copolymer - chemistry Rats Release kinetics control Sustained drug delivery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!